We reported here that FL090, acting as an LRRK2 kinase inhibitor, ameliorated motor behavioral deficits and rescued the dopaminergic neuron loss in both intoxicated and α‐syn‐related parkinsonism rodent models. The gene discussed is LRRK2; the disease is Parkinsonism.